ARTICLE AD BOX
The Eli Lilly and Novo Nordisk logos.
Mike Blake | Tom Little | Reuters
It's a tale of two drugmakers in the red-hot obesity drug market.
Both Read Entire Article
Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
3 hours ago
1
RIGHT SIDEBAR TOP AD
Popular
RIGHT SIDEBAR BOTTOM AD
English (US) ·
About Us ·
Contact Us ·
Terms & Conditions ·
Privacy Policy ·
DMCA ·
Cookie Policy ·
Advertise With Us ·
© Primetweets 2026. All rights are reserved